Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03881267 · ClinicalTrials.gov registry record · NA
SkinTE® in the Treatment of Venous Leg Wounds
A NA study, sponsored by PolarityTE.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03881267: Completed NA study, sponsored by PolarityTE.
NCT03881267 is a NA study that has completed, run by PolarityTE. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03881267, a NA study, has completed, sponsored by PolarityTE.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on a commercially available human autologous homologous skin construct with SOC dressing compared to SOC dressings alone in the treatment of Venous Leg Wounds
Primary Outcome
examine percent of ulcers healed at week twelve
Interventions
- OTHER Additional Outer Dressing Application
- OTHER Fibracol Wound Dressing
- OTHER Human Autologous Homologous Skin Construct
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2019-03-29 |
| Est. Completion | 2021-03-23 |
| Phase | NA |
What the finished NCT03881267 record still lists
NCT03881267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Additional Outer Dressing Application is the first listed.
NCT03881267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03881267 about?
NCT03881267 is a clinical study titled "SkinTE® in the Treatment of Venous Leg Wounds". This study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on a commercially available human autologous homologous skin construct with SOC dressing compared to SOC dressings alone in the treatment of Venous Leg Wounds
What is the current status of trial NCT03881267?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2019-03-29. Estimated completion is 2021-03-23.
What interventions are being tested in trial NCT03881267?
The interventions under investigation include: Additional Outer Dressing Application (OTHER), Fibracol Wound Dressing (OTHER), Human Autologous Homologous Skin Construct (OTHER).
Who is sponsoring clinical trial NCT03881267?
This trial is sponsored by PolarityTE, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03881267's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI